Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-03-05 @ 2:01 PM
Study NCT ID:
NCT02619669
Status:
WITHDRAWN
Last Update Posted:
2020-03-12
First Post:
2015-11-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer
Sponsor:
Gary Schwartz
Organization: